The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Exposure of Adolescent Rats to Oral Methylphenidate: Preferential Effects on Extracellular Norepinephrine and Absence of Sensitization and Cross-Sensitization to Methamphetamine
Open accessAbstract
Methylphenidate (MP) (ritalin) is widely used in the treatment of children and adolescents with attention deficit hyperactivity disorder, but little is known about therapeutic mechanisms or about possible consequences of long-term exposure. To more closely simulate the clinical use of the drug, we orally administered MP to adolescent rats during the dark-active phase of the circadian cycle at doses (0.75-3.0 mg/kg) below threshold for locomotor activation. We found that doses in this range increased extracellular norepinephrine in hippocampus without affecting dopamine in nucleus accumbens. These results suggest that norepinephrine systems may play an important role in the therapeutic action of this drug. To examine one potential consequence of long-term exposure to MP, i.e., the development of locomotor sensitization, an adaptational change that has been implicated in drug abuse liability, animals received three daily oral administrations of these doses of MP for up to 4 weeks through adolescence. The animals were then challenged with methamphetamine (0.5 mg/kg). We found that the behavioral response to MP did not change during the course of chronic treatment and that MP-pretreated animals did not exhibit a sensitized locomotor response to the methamphetamine challenge. We propose that, to the extent that this treatment protocol more closely reflects clinical exposure patterns, the relative insensitivity of accumbens dopamine to the acute administration of these MP doses, and the corresponding absence of evidence for the development of locomotor sensitization, supports one clinical view that there is little abuse liability associated with low dose, long-term MP treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lower doses in rats improve PFC attention and working memory function, enhance PFC neuronal response, and reduce locomotor hyperactivity in juveniles (Arnsten and Dudley, 2005; Berridge et al., 2006; Kuczenski and Segal, 2002).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Kuczenski and Segal, 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When administered in appropriate doses, these medications improve PFC function both in healthy human subjects (Elliott et al., 1997) and in animals (Arnsten and Dudley, 2005), including the reduction of locomotor hyperactivity in juvenile rats (Kuczenski and Segal, 2002).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Kuczenski and Segal, 2002
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Robinson, T. G., & BECKER, J. (1986) · Brain Research · doi:10.1016/s0006-8993(86)80193-7 · Cited by 2,108
Robinson, T. E., & Becker, J. B. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90002-0 · Cited by 1,796
Biederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498
Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,360
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
D1 receptors in prefrontal cells and circuits
Goldman-Rakic, P. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00045-4 · Cited by 822
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., & Franceschi, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0001.2001 · Cited by 770
Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666
Research works printed but not linked: 3
- Sagvolden T (2001) The spontaneously hypertensive rat as a model for ADHD. In: Stimulant drugs and ADHD: basic and clinical neuro- science (Solanto MV, Arnsten AFT, Castellanos FX, eds), pp 221-237. New York: Oxford UP.
- Solanto MV, Arnsten AFT, Castellanos FX (2001) The neuroscience of stimulant drugs in ADHD. In: Stimulant drugs and ADHD: basic and clinical neuroscience (Solanto MV, Arnsten AFT, Castellanos FX, eds), pp 355-379. New York: Oxford UP.
- Taylor JR, Jentsch JD (2001) Stimulant effects on striatal and cortical dopamine systems involved in reward-related behavior and impulsivity: implications for ADHD. In: Stimulant drugs and ADHD: basic and clinical neuroscience (Solanto MV, Arnsten AFT, Castellanos FX, eds), pp 104 -133. New York: Oxford UP.
Cited by
Sorted by citations
Items 201–300 of 317
Withdrawal from methylphenidate increases neural reactivity of dorsal midbrain
Ferreira, R., Bassi, G. S., Cabral, A. E. A., & Nobre, M. J. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.08.009 · Cited by 11
McFadden, L. M., & Matuszewich, L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.016 · Cited by 13
Fuller, J., Burrell, M., Yee, A. G., Liyanagama, K., Lipski, J., Wickens, J. R., & Hyland, B. I. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101681 · Cited by 13
Methylphenidate modulates the locus ceruleus neuronal activity in freely behaving rat
Tang, B., & Dafny, N. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.08.016 · Cited by 12
The effects of methylphenidate on cognitive performance of healthy male rats
Rostron, C. L., Kaplan, E., Gaeta, V., Nigriello, R., & Dommett, E. J. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00097 · Cited by 11
Chu, R., Shumsky, J. S., & Waterhouse, B. D. (2015) · Brain Research · doi:10.1016/j.brainres.2015.11.039 · Cited by 11
Methylphenidate has long-lasting metaplastic effects in the prefrontal cortex of adolescent rats
Burgos, H., Cofré, C., Hernández, A., Sáez‐Briones, P., Agurto, R., Castillo, A., Morales, B., & Zeise, M. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.009 · Cited by 12
Ponchio, R. A., Teodorov, E., Kirsten, T. B., Coelho, C. D. P., Oshiro, A., Flório, J. C., & Bernardi, M. M. (2015) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2015.05.008 · Cited by 12
Integrative proteomics and pharmacogenomics analysis of methylphenidate treatment response
da Silva, B. S., Leffa, D. T., Beys-da-Silva, W. O., Torres, I. L. S., Rovaris, D. L., Victor, M. M., Rohde, L. A., Mota, N. R., Oliveira, C. D., Berger, M., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0649-5 · Cited by 12
Gauthier, J. M., Tassin, D. H., Dwoskin, L. P., & Kantak, K. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.018 · Cited by 13
Fotopoulos, N. H., Devenyi, G. A., Guay, S., Sengupta, S. M., Chakravarty, M. M., Grizenko, N., Karama, S., & Joober, R. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102695 · Cited by 10
Effects of Methylphenidate on the Dopamine Transporter and Beyond
Zetterström, T., Quansah, E., & Grootveld, M. C. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_333 · Cited by 11
Trinh, T. N., Kohlleppel, S., Yang, P. B., Burau, K. D., & Dafny, N. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1063-4 · Cited by 11
Amodeo, L. R., Jacobs-Brichford, E., McMurray, M. S., & Roitman, J. D. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.02.019 · Cited by 11
Differential effects of alprazolam against methylphenidate-induced neurobehavioral alterations
Dutt, M., Dharavath, R. N., Kaur, T., Chopra, K., & Sharma, S. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112935 · Cited by 11
Chronic preexposure to methylphenidate cross-sensitizes methamphetamine in male Japanese quail
Rosine, B. J., Bolin, B. L., & Akins, C. K. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832ec615 · Cited by 11
Pharmacokinetic and pharmacodynamic analysis of d-amphetamine in an attention task in rodents
Slezak, J. M., Mueller, M., Ricaurte, G. A., & Katz, J. L. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000409 · Cited by 11
Cassaday, H. J., Finger, B., & Horsley, R. R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107083842 · Cited by 10
Venkataraman, S. S., Joseph, M. J. E., & Dafny, N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.11.004 · Cited by 10
Prepubertal methylphenidate leads to sex-dependent differences in probabilistic discounting
Kelly, G., Bezenah, J. C., Tejada, A. N., Johnson, B., Vazquez, B., Espinosa, M., & Amodeo, L. R. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173424 · Cited by 9
Cortical alterations associated with lower response to methylphenidate in adults with ADHD
Parlatini, V., Andrews, D. S., Pretzsch, C. M., Arenella, M., Daly, E., Ecker, C., & Murphy, D. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00228-y · Cited by 9
Callovini, T., Janiri, D., Segatori, D., Mastroeni, G., Kotzalidis, G. D., Nicola, M. D., & Sani, G. (2024) · Pharmaceuticals · doi:10.3390/ph17081076 · Cited by 9
Fowler, S. C., Zarcone, T. J., & Levant, B. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.03.014 · Cited by 9
Teuns, G., Geys, H., Geuens, S., Stinissen, P., & Meert, T. F. (2014) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2014.02.002 · Cited by 9
Kharas, N., Reyes-Vázquez, C., & Dafny, N. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1760-5 · Cited by 9
Popat, P., Dinu, L. M., Runswick, O. R., Findon, J. L., & Dommett, E. J. (2021) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-021-00662-4 · Cited by 9
Perspective on the status of preclinical models for psychiatric disorders
Winsky, L., & Brady, L. S. (2005) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2005.11.007 · Cited by 9
The Roles of Norepinephrine and Serotonin in Attention Deficit Hyperactivity Disorder
Oades, R. D. (2005) · Contemporary clinical neuroscience · doi:10.1385/1-59259-891-9:097 · Cited by 9
Physical exercise affects attentional orienting behavior through noradrenergic mechanisms.
Robinson, A. M., Buttolph, T. R., Green, J. T., & Bucci, D. J. (2015) · Behavioral Neuroscience · doi:10.1037/bne0000054 · Cited by 9
Baladi, M. G., Nielsen, S. M., Umpierre, A. D., Hanson, G. R., & Fleckenstein, A. E. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000094 · Cited by 8
Zhang‐James, Y., Lloyd, D. R., James, M. L., Yang, L., Richards, J. B., & Faraone, S. V. (2019) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20190021 · Cited by 8
Wetzell, B., & Riley, A. L. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.02.002 · Cited by 7
A Dopamine D1 Agonist Versus Methylphenidate in Modulating Prefrontal Cortical Working Memory
Yang, Y., Lewis, M. M., Kong, L., & Mailman, R. B. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001215 · Cited by 7
Horvat, L., Foschini, A., Grinias, J. P., Waterhouse, B. D., & Devilbiss, D. M. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149040 · Cited by 7
GarcÃa-Avilés, Ã., Albert-Gascó, H., Arnal-Vicente, I., Elhajj, E., Sanjuan-Arias, J., Sanchez-Perez, A. M., & Olucha-Bordonau, F. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00033 · Cited by 7
Methylphenidate induces state-dependency of social recognition learning: Central components
Zinn, C. G., Bühler, L., Cavalcante, L. E. S., Schmidt, S. D., Ferreira, F. F., Zanini, M. L., Furini, C. R. G., Myskiw, J. D. C., & Izquierdo, I. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.02.002 · Cited by 7
Turner, A., Stramek, A. K., Kraev, I., Stewart, M. G., Overton, P. G., & Dommett, E. J. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118763984 · Cited by 7
Dual Neurostimulant Therapy May Optimize Acute Neurorecovery for Severe Traumatic Brain Injuries
Tracy, B. M., Silverman, M. E., Cordero-Caballero, C., Durr, E. A., & Gelbard, R. B. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2021.07.037 · Cited by 6
Montiel-Herrera, F., Batanero-Geraldo, A., López, J. C., Vargas, J. P., Quintero, E., & Díaz, E. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114526 · Cited by 5
Juárez, J., & Vázquez‐Cortés, C. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.093 · Cited by 6
Baskin, B. M., Dhonnchadha, B. Á. N., Dwoskin, L. P., & Kantak, K. M. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4681-y · Cited by 5
Rezin, G., Scaini, G., Ferreira, G., Cardoso, M. R., Gonçalves, C. L., Constantino, L., Deroza, P. F. P., Ghedim, F. V., Valvassori, S., Resende, W. R., et al. (2012) · Metabolic brain disease · doi:10.1007/s11011-012-9331-9 · Cited by 7
Locus Coeruleus Neuronal and Behavioral Activity Following Acute and Chronic Methylphenidate
Tang, B., & Dafny, N. (2015) · Journal of Brain Sciences · doi:10.18488/journal.83/2015.1.1/83.1.24.42 · Cited by 6
Urban, K. R., Li, Y., Xing, B., & Gao, W. (2016) · Journal of Reward Deficiency Syndrome and Addiction Science · doi:10.17756/jrdsas.2016-030 · Cited by 6
Time-shifting effects of methylphenidate on daily rhythms in the diurnal rodent Arvicanthis ansorgei
Mendoza, J., van Diepen, H. C., Pereira, R. R., & Meijer, J. H. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4928-2 · Cited by 5
Knol, R. J. J., de Bruin, K. M., van Eck‐Smit, B. L. F., & Booij, J. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0620-1 · Cited by 5
Arnsten, A. F. T., & Vijayraghavan, S. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00373.2006 · Cited by 5
Jaboinski, J., Cabral, J. C. C., Campos, R. C., & Barros, D. M. (2015) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2014-0060 · Cited by 4
Attention deficit hyperactivity disorder
Berridge, C. W., Devilbiss, D. M., Spencer, R. C., Schmeichel, B. E., & Arnsten, A. F. T. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.018 · Cited by 4
Reyes-Vasquez, C., Jones, Z., Tang, B., & Dafny, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316628 · Cited by 4
Rafaiee, R., Ahmadiankia, N., Mousavi, S. A., Rezaeian, L., Sarvandani, M. N., Shekari, A., Forouzesh, M., Valipour, R., & Moghaddam, H. K. (2019) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.90561 · Cited by 4
Peña, I. D., Ahn, H. S., Shin, C., & Cheong, J.-H. (2011) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2011.19.1.009 · Cited by 4
Arnold, A., Persike, M., Gorka, J., Dommett, E. J., Zimmermann, M., & Karas, M. (2015) · Journal of Mass Spectrometry · doi:10.1002/jms.3605 · Cited by 4
Fuster, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-407815-4.00003-9 · Cited by 4
Berridge, C. W., & Devilbiss, D. M. (2012) · Psiquiatría Biológica · doi:10.1016/j.psiq.2012.07.001 · Cited by 3
Effects of Methylphenidate and Atomoxetine on Development of the Brain
Altunkaynak, B. Z., Önger, M. E., Türkmen, A. P., Yurt, K. K., Altun, G., Yuce, M., & Kaplan, S. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_48 · Cited by 3
Turner, A. C., Kraev, I., Stewart, M., Stramek, A., Overton, P., & Dommett, E. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.033 · Cited by 2
A Biological/Genetic Perspective: The Addicted Brain
Kelly, T. H., Kazura, A. N., Lommel, K. M., Babalonis, S. L., & Martin, C. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-09732-9_2 · Cited by 3
Efeito da pré-exposição a dietilpropiona e a cafeína sobre o valor reforçador da dietilpropiona
García‐Mijares, M. (2005) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.47.2005.tde-18092006-155123 · Cited by 3
Yates, J. R., Broderick, M. R., Berling, K. L., Gieske, M. G., Osborn, E., Nelson, M. R., & Wright, M. R. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110970 · Cited by 2
Spencer, R. C., Martin, A. J., Devilbiss, D. M., & Berridge, C. W. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01738-6 · Cited by 2
Schmitz, F., Durán‐Carabali, L. E., Rieder, A. S., Silveira, J. S., Júnior, O. V. R., Bobermin, L. D., Quincozes‐Santos, A., Alves, V. S., Coutinho‐Silva, R., Savio, L. E. B., et al. (2024) · Neurotoxicity Research · doi:10.1007/s12640-024-00718-y · Cited by 2
DOES METHYLPHENIDATE ENHANCE COGNITION IN NORMAL RATS AND DOES IT AFFECT NEURONAL POPULATION
Ravichandran, N., Madhyastha, S., Elenjickal, V. M., Joy, T., Blossom, V., & Pai, M. M. (2015) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 2
Adult ADHD: Future Directions for Practice and Research
Pallanti, S., & Salerno, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-39051-8_20 · Cited by 2
Fuster, J. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373644-4.00003-7 · Cited by 2
Miller, B. (2004) · doi:10.12794/metadc4689 · Cited by 2
Brain Development and the Risk for Substance Use, Misuse, and Substance Use Disorders
Ruiz, S. G., Casey, B. J., & Baskin-sommers, A. R. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197640654.003.0049 · Cited by 1
Methylphenidate leads to disruptions in rest/wake patterns after discontinuation
del Cueto, C. R., Gonzales, M. R., Tejada, A. N., Leon, K., Mora, A., Cabrera, A., & Amodeo, L. R. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06859-y · Cited by 1
Soares-Couto, P., Sá, S. I., Costa, V. M., Dias-Carvalho, A., Ferreira, M., Carvalho, F. D., Meisel, A., & Capela, J. P. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04712-y · Cited by 1
Efecto de agonistas y antagonistas de la dopamina en ambientes de reforzamiento variables
Trápaga, J. A. B., & Naranjo, C. F. A. (2008) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Child psychopharmacology: Is it more similar than different from adult psychopharmacology?
Trivedi, J., & Sareen, H. (2013) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.117158 · Cited by 1
Measuring Effects of Psychostimulants on Egocentric Spatial Learning and Memory in Adult Zebrafish
Nasir, R., Choezom, T., Cunningham, J., Bajaj, B. V. M., Rubí, C., Butler, J., Arroyo, K., & Schroeder, J. A. (2012) · Neuromethods · doi:10.1007/978-1-61779-597-8_18 · Cited by 1
Cummins, E. D., Leedy, K. K., Dose, J. M., Peterson, D. J., Kirby, S., Hernandez, L. J., & Brown, R. W. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116681458 · Cited by 1
Chronic amphetamine treatment affects collicular‐dependent behaviour
Turner, A. C., Stramek, A., Kraev, I., Stewart, M., Overton, P., & Dommett, E. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.01.028 · Cited by 2
SumeraKanwal, Haleem, D. J., NaziaFeroz, Ammar, B., & Imtiaz, F. (2021) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2021.17.1.0290 · Cited by 1
Edemann-Callesen, H., Glienke, M., Akinola, E. O., Lieser, M. K., Habelt, B., Hadar, R., Bernhardt, N. R., & Winter, C. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03029-5 · Cited by 1
Evaluation of Bone Mineral Density in Rats Administered Methylphenidate
Türkbay, T., Cöngöloğlu, M. A., Sargın, H., Dündaröz, R., & Söhmen, T. (2003) · Psychiatry and Clinical Psychopharmacology · Cited by 1
Catecholamine influences on prefrontal cortex circuits and function
Arnsten, A. F. T., & Berridge, C. W. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.015 · Cited by 1
Yuan, A., Claussen, C. M., Jones, Z., Tang, B., & Dafny, N. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02665-y · Cited by 1
Miller, E. M. (2014) · UKnowledge (University of Kentucky) · Cited by 1
Effects of Dopamine Agonists and Antagonists in Variable Reinforcing Environments
Trápaga, J. A. B., & Naranjo, C. F. A. (2008) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Philipsen, M. H., Phan, N. T. N., Fletcher, J. S., & Ewing, A. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.08.899401 · Cited by 1
Somkuwar, S. S. (2013) · UKnowledge (University of Kentucky)
Behavioral responses to methylphenidate: correlations with neuronal activity in the caudate nucleus
Claussen, C. M. (2013) · Digital Commons-TMC (Texas Medical Center)
Studies on neurodevelopmental issues in children
FERON, F. J. M. (2007) · doi:10.26481/dis.20070209ff
On the influence of dopamine-related genetic variation on dopamine-related disorders
Bergman, O. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Metilfenidato causa alterações neuroquímicas e comportamentais em ratos
Scherer, E. B. D. S. (2010) · Americanae (AECID Library)
Jones, Z. (2013) · Digital Commons-TMC (Texas Medical Center)
Villemonteix, T. (2015) · theses.fr (ABES) · doi:10.70675/84304c2az6a4fz488czbda7z8935968796d4 · Cited by 1
Possible alteration of catecholaminergic transporters in specific brain areas of iron deficit rats
Mohamed, W. M. Y. (2015) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.220106
Methylphenidate Increases cGMP Levels in Rat Brain
Türkbay, T., Cöngöloğlu, M. A., Doruk, A., Aydın, A., & Sayal, A. (2005) · Psychiatry and Clinical Psychopharmacology
Attention-Deficit/Hyperactivity Disorder as a Metabolic Encephalopathy
Russell, V. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-79112-8_19
Vijayraghavan, S., Totah, N. K. B., Kim, Y. B., Homayoun, H., & Moghaddam, B. (2015)
Gronier, B., Aston, J., Liauzun, C., & Zetterström, T. (2011)
Trace amine associated receptors : a new target for medications in drug addiction
Cotter, R. (2012) · UC Research Repository (University of Canterbury) · doi:10.26021/5624
Gill, K. E. (2013) · WakeSpace Scholarship (Wake Forest University)
The effects of modafinil and atomoxetine on dopamine signaling in the striatal subregions of the rat
Bobák, M. (2015) · ISU Red - Research and eData (Illinois State University) · doi:10.30707/etd2015.bobak.m
Pardey, M. C., Kumar, N. N., Goodchild, A. K., Clemens, K. J., Homewood, J., & Cornish, J. L. (2012)
Methylphenidate and Addiction in Rats
Geller, B. (2002) · Journal watch · doi:10.1056/jp200212040000004
Basic mechanisms and treatment planning/targets for attention-deficit/hyperactivity disorder
Franke, B., & Buitelaar, J. K. (2020) · doi:10.1093/med/9780198713005.003.0032
Metadata
- Authors
- Kuczenski, R., & Segal, D. S.
- Affiliations
- University of California San Diego (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 7264-7271
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6757883
- OpenAlex
- W2159875740
- Cited by
- 316
- References
- 75
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 7 · 2019: 6 · 2018: 12 · 2017: 12 · 2016: 10 · 2015: 28 · 2014: 16 · 2013: 21 · 2012: 21
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- University of California, San Diego
- National Institute on Drug Abuse (R01DA001568)
- NIH Clinical Center
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- methylphenidate, adolescent rats, hippocampus, nucleus accumbens dopamine, locomotor sensitization, cross-sensitization, abuse liability, attention deficit hyperactivity disorder, long-term drug exposure
- MeSH terms
- Administration, Oral, Age Factors, Animals, Behavior, Animal, Dopamine, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Interactions, Extracellular Space, Hippocampus, Male, Methamphetamine, Methylphenidate, Motor Activity, Norepinephrine, Nucleus Accumbens, Time, Rats, Sprague-Dawley, Microdialysis, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
